www.pharmavoice.com
Open in
urlscan Pro
2606:4700:4400::ac40:9886
Public Scan
Submitted URL: https://r.smartbrief.com/resp/sBAfCOxHxeDDsDzyCigmghBWcNySxC?format=multipart
Effective URL: https://www.pharmavoice.com/news/pv100-pharma-leaders-executives/726233/
Submission: On October 23 via api from SA — Scanned from DE
Effective URL: https://www.pharmavoice.com/news/pv100-pharma-leaders-executives/726233/
Submission: On October 23 via api from SA — Scanned from DE
Form analysis
5 forms found in the DOMName: signup-inter-form — POST /signup/
<form id="signup-inter-form" class="form-basic" name="signup-inter-form" action="/signup/" method="POST">
<input type="hidden" name="signup_box_location" value="interstitial">
<input type="hidden" name="signup_initial_url_path" value="">
<h1> Don’t miss the most important voices in pharma </h1>
<p class="interstitial-text"> Let PharmaVoice’s free newsletter keep you informed on what industry leaders are saying, straight from your inbox. </p>
<p class="form-error__message" id="interstitial-error"></p>
<div id="form-interstitial">
<input type="email" name="email" placeholder="Work email address" class="email" required="" id="id_3e86ff_email">
<div id="newsletter-list-section">
</div>
<div id="interstitial-consent-container">
<input name="user_consent" value="1" id="id_user_consent" type="checkbox">
<span> By signing up to receive our newsletter, you agree to our <a href="https://www.industrydive.com/terms-of-use/" target="_blank">Terms of Use</a> and
<a href="https://www.industrydive.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span>
</div>
</div>
<input id="signup-inter-submit" class="email_submit submit button" type="submit" data-role="none" value="Subscribe today">
</form>
GET /search/
<form action="/search/" method="GET">
<label for="search-desktop">
<span class="screen-reader-text search">Search</span>
</label>
<input id="search-desktop" type="Search" name="q" placeholder="search">
<button type="submit" value="" class="search-button-front analytics t-search-navigation-drawer">
<img src="/static/images/proformative_search_glass_black.svg?231516061021" width="18" height="18" alt="search" loading="lazy">
</button>
<img class="close" src="/static/img/menu_icons/close.svg?273117231121" width="16" height="16" loading="lazy" alt="close search">
</form>
Name: signup — POST /signup/
<form class="form js-form-email-validate" name="signup" action="/signup/" method="POST">
<label for="id_be7ef_email" class="email-input js-email-input">
<span class="screen-reader-text">Email:</span>
<input type="email" name="email" placeholder="Work email address" class="email" required="" id="id_be7ef_email">
</label>
<input type="hidden" name="signup_box_location" value="elevated_footer">
<input type="hidden" name="signup_initial_url_path" value="/news/pv100-pharma-leaders-executives/726233/">
<input type="hidden" name="js_enabled" value="1" id="id_be7ef_js_enabled">
<ul class="signup-list list-no-bullets">
<li>
<label><span class="screen-reader-text">Select user consent:</span></label>
<input type="checkbox" name="user_consent" id="id_user_consent-elevated_footer" value="1" class="checkbox">
<label for="id_user_consent-elevated_footer">
<span class="signup-user-consent_box">
<span> By signing up to receive our newsletter, you agree to our <a href="https://www.industrydive.com/terms-of-use/" target="_blank">Terms of Use</a> and
<a href="https://www.industrydive.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span>
</span>
</label>
</li>
</ul>
<button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button>
<script type="module" src="/static/js/dist/sendEmailToLytics.bundle.js?420316211024"></script>
<label class="error email_error" style="display:none;">A valid email address is required.</label>
<label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label>
</form>
GET /search/
<form action="/search/" method="GET" data-ajax="false">
<label for="search-mobile">
<span class="screen-reader-text">Search</span>
<input id="search-mobile" type="search" name="q" placeholder="Search" data-role="none">
</label>
<button type="submit" value="" data-role="none" class="search-button-front analytics t-search-navigation-mobile">
<img src="/static/img/menu_icons/search.svg?320116291121" width="15" height="15" alt="search">
</button>
</form>
Name: signup — POST /signup/
<form class="form js-form-email-validate" name="signup" action="/signup/" method="POST">
<label for="id_d16a7b_email" class="email-input js-email-input">
<span class="screen-reader-text">Email:</span>
<input type="email" name="email" placeholder="Work email address" class="email" required="" id="id_d16a7b_email">
</label>
<input type="hidden" name="signup_box_location" value="integrated_menu">
<input type="hidden" name="signup_initial_url_path" value="/news/pv100-pharma-leaders-executives/726233/">
<input type="hidden" name="js_enabled" value="1" id="id_d16a7b_js_enabled">
<ul class="signup-list list-no-bullets">
<li>
<label><span class="screen-reader-text">Select user consent:</span></label>
<input type="checkbox" name="user_consent" id="id_user_consent-integrated_menu" value="1" class="checkbox">
<label for="id_user_consent-integrated_menu">
<span class="signup-user-consent_box">
<span> By signing up to receive our newsletter, you agree to our <a href="https://www.industrydive.com/terms-of-use/" target="_blank">Terms of Use</a> and
<a href="https://www.industrydive.com/privacy-policy/" target="_blank">Privacy Policy</a>. You can unsubscribe at anytime. </span>
</span>
</label>
</li>
</ul>
<button class="button button--medium signup-button" type="submit" value="Sign up">Sign up</button>
<script type="module" src="/static/js/dist/sendEmailToLytics.bundle.js?420316211024"></script>
<label class="error email_error" style="display:none;">A valid email address is required.</label>
<label class="error newsletter-error" style="display:none;">Please select at least one newsletter.</label>
</form>
Text Content
Skip to main content CONTINUE TO SITE ➞ DON’T MISS THE MOST IMPORTANT VOICES IN PHARMA Let PharmaVoice’s free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. * Voices * Q&A * Profiles * Biotech Spotlight * First 90 Days * Opinions * Topics * Biotech * Commercialization * Leadership * Manufacturing * Patient * Pharma * Policy & Regulation * Research & Development * Library * Events * Press Releases * PharmaVoice 100 * Nominate * 2024 PV100 * 2023 PV100 Sign up * Search * Sign up Search THE 2024 PHARMAVOICE 100 Industry leaders reshaping the pharma world. Published October 8, 2024 • By PharmaVoice staff Illustration: Vartika Sharma for Industry Dive The pharma industry is always transforming. Scientific and business advances build on achievements from the past, and major breakthroughs reshape the market. Behind the many changes of the last year are the leaders that drive that transformation, and their advances have been prolific. GLP-1 agonists once primarily used for diabetes shifted to obesity and found runaway success. Advances in gene therapies paved the way to the approval of the first gene editing CRISPR drug. Leaps in oncology such as CAR-T cell therapies are improving with off-the-shelf treatments that could open the manufacturing bottleneck. Emerging AI and machine learning tools are increasingly impacting a wide array of pharma operations. In the backdrop of this forward momentum, the industry is adapting to the market’s shifting landscape — the biotech sector’s recovery, new pricing regulations brought by the Inflation Reduction Act and the ongoing push to move the needle on equity goals have all shaped that ecosystem. This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions. Our list salutes leaders who are not only navigating these changes, but at times, forging new paths for others to follow. These are some of the industry’s most inspiring professionals, honored in 10 distinct categories: Standout Leaders, Clinical Trial Pros, Trailblazers, Patient Champions, Biotech Pathfinders, Cancer Care Visionaries, Cardiometabolic All-stars, Cell and Gene Therapy Pioneers, Rare Disease Warriors, and Tech and AI Wizards. Here are this year’s PharmaVoice 100 honorees. Editor’s note: We received hundreds of submissions this year and making final cuts wasn’t easy. Thank you so much to the many leaders across the industry who put forth the names of pharma’s inspiring individuals. We’d love to consider them again next year. And nominations for next year’s list are open! Please submit your nominations by May 5, 2025. Find an honoree Search for a person or company: CATEGORIES › * All categories * Standout leaders * Clinical trial pros * Trailblazers * Patient champions * Biotech pathfinders * Cancer care visionaries * Cardiometabolic all-stars * Cell and gene therapy pioneers * Rare disease warriors * Tech and AI wizards COMPANIES › * All companies * 4D Molecular Therapeutics * 89bio * AbbVie * Alector * Alexion * Alkermes * Altasciences * Altimmune * Argenx * Ascidian Therapeutics * AstraZeneca * Avalyn Pharma * Avidity Biosciences * BPGbio * Bayer * BioAge Labs * Bios Health Group * Black Women in Clinical Research * Boehringer Ingelheim * Bristol Myers Squibb * CTMC * Cardiff Oncology * Caribou Biosciences * Certara * Cleveland Diagnostics * Click Therapeutics * Coya Therapeutics * Cullinan Therapeutics * Cytokinetics * Daiichi Sankyo * Dynavax Technologies * EY * Eascra Biotech * Eisai * Elicio Therapeutics * Er-Kim Pharmaceuticals * Eversana * Exscientia * Ferring Pharmaceuticals * Flagship Pioneering * GSK * Genmab * Geron * Grail * Guardant Health * Halia Therapeutics * ICON * IQVIA * Incyte * Insmed * Jazz Pharmaceuticals * Johnson & Johnson * Karuna Integrated Clinical Services * Kura Oncology * Kymera Therapeutics * Lexeo Therapeutics * Lightship * Lilly Gateway Labs * Lisata Therapeutics * Lundbeck * Madrigal Pharmaceuticals * McKesson * Merck & Co. * Multiple Myeloma Research Foundation * Novavax * Novo Nordisk * Palleon Pharmaceuticals * Parexel * PathAI * Pharmaceutical Research and Manufacturers of America * Poseida Therapeutics * Prothena * Regeneron Pharmaceuticals * Rocket Pharmaceuticals * Rondo Therapeutics * Scribe Therapeutics * Seqster * SmartLabs * Syneos Health * Takeda * Takeda Pharmaceuticals * Tasso * The START Center for Cancer Research * Travere Therapeutics * Trevi Therapeutics * TriLink Biotechnologies * Tune Therapeutics * Ultragenyx Pharmaceutical * Umoja Biopharma * VectorBuilder * Verana Health * Vertex Pharmaceuticals * Vincerx Pharma * Worldwide Clinical Trials * Zymeworks * iEcure * All companies HONOREES › * All honorees * Hesham Abdullah * Aruna Adhikari * Eric Adler * Nadim Ahmed * Shelley Force Aldred * Michael Andreini * Ardy Arianpour * Barry Balfe * Lyn Baranowski * Aris Baras * David Bearss * Soraya Bekkali * Howard Berman * Robert Blum * Jason Bock * Chris Bouton * Sarah Boyce * Ben Casavant * Arnon Chait * Aimee Christian * Raffaele Colombo * Peter DeMuth * Joe DePinto * Gary Dubin * Samantha Eells * Michael Ehlers * Yusri Elsayed * Mark Erlander * Faye Feller * Kathleen Ford * Kristen Fortney * Vipin Garg * Thomas Gibbs * Julie Gilmore * Jared Gollob * Jennifer Good * Marjorie Green * Craig Hopkinson * Zizi Uzezi Imatorbhebhe * Michael Irizarry * Raquel Izumi * Sujay Jadhav * Alyssa Johnsen * Avak Kahvejian * David Kamenir * Steve Kanner * Teri Karcher * Tina Karunaratne * Sara Kenkare-Mitra * Gene Kinney * David Kirn * David Benshoof Klein * Nikolaus Krall * Bruce Lahn * Heather Lau * Will Lewis * Mohit Manrao * Carlos Martin * David Mazzo * Danielle Mitchell * Negelle Morris * Niven Narain * Biljana Naumovic * Benjamin Oakes * Andrew Otoo * Rohan Palekar * Amita Patnaik * Li Peng * Daniel Perez * Mary Pinder-Schenck * Kim Ribeiro * William Rote * Christine Roth * Christine Sakdalan * Andrew Scharenberg * Cheryl Schwartz * Venkat Sethuraman * Beatrice Setnik * Jade Shields * Amoolya Singh * Greg Skalicky * Mari Anne Snow * Ryan Spencer * James Stansel * Steven Stein * AmirAli Talasaz * Nia Tatsis * Rebecca Taub * Silvia Taylor * Brian Taylor * Joe Truitt * Luc Truyen * Arda Ural * Martine van Vugt * Eric Walk * Jane Williams * Kristin Yarema * Heidi Zhang * Chanfeng Zhao * Cem Zorlular * All honorees STANDOUT LEADERS NADIM AHMED CEO, president, Cullinan Therapeutics AIMEE CHRISTIAN Former vice president, global head, corporate communications and engagement, Jazz Pharmaceuticals KATHLEEN FORD Chief operating officer, Kura Oncology THOMAS GIBBS Executive vice president, head, Lundbeck U.S.; president, Lundbeck ZIZI UZEZI IMATORBHEBHE CEO, executive partner, Bios Health Group DAVID KAMENIR Vice president, North America enterprise strategy and business development, Novo Nordisk GENE KINNEY CEO, president, Prothena DR. DAVID KIRN CEO, co-founder, 4D Molecular Therapeutics WILL LEWIS CEO, chair, Insmed MOHIT MANRAO Senior vice president, head, U.S. oncology, AstraZeneca DAVID MAZZO CEO, president, Lisata Therapeutics CHRISTINE ROTH Member, executive committee, Bayer’s pharmaceuticals division; head, global product strategy and commercialization, Bayer CHRISTINE SAKDALAN Therapeutic area head, mental health, Boehringer Ingelheim GREG SKALICKY President, Eversana JAMES STANSEL Executive vice president, general counsel, corporate secretary, the Pharmaceutical Research and Manufacturers of America SILVIA TAYLOR Chief corporate affairs and advocacy officer, executive vice president, Novavax ARDA URAL Americas life sciences leader, EY MARTINE VAN VUGT Chief strategy officer, executive vice president, Genmab CLINICAL TRIAL PROS BARRY BALFE President, pharma development solutions, ICON BEN CASAVANT CEO, co-founder, Tasso SAMANTHA EELLS Co-founder, Lightship SUJAY JADHAV CEO, Verana Health TERI KARCHER Chief drug development officer, executive vice president, head, launch excellence, Parexel TINA KARUNARATNE CEO, founder, Karuna Integrated Clinical Services DANIELLE MITCHELL CEO, founder, Black Women in Clinical Research DR. BEATRICE SETNIK Chief scientific officer, Altasciences CHANFENG ZHAO Vice president, R&D chemistry, TriLink Biotechnologies TRAILBLAZERS PETER DEMUTH Chief scientific officer, Elicio Therapeutics DR. GARY DUBIN President, global vaccine business, Takeda Pharmaceuticals DR. FAYE FELLER Chief medical officer, executive vice president, Geron DR. JARED GOLLOB Chief medical officer, Kymera Therapeutics DR. CRAIG HOPKINSON Chief medical officer, senior vice president, clinical development and medical affairs, Alkermes DR. MICHAEL IRIZARRY Deputy chief clinical officer, clinical evidence generation, deep human biology learning; senior vice president, clinical research, neurology, Eisai DR. ALYSSA JOHNSEN Senior vice president, head, clinical development for immunology, cardiovascular and neuroscience, Bristol Myers Squibb STEVE KANNER Chief scientific officer, Caribou Biosciences SARA KENKARE-MITRA President, head, research and development, Alector LI PENG Chief scientific officer, Palleon Pharmaceuticals DR. STEVEN STEIN Chief medical officer, executive vice president, Incyte DR. LUC TRUYEN Chief medical officer, Argenx PATIENT CHAMPIONS MICHAEL ANDREINI CEO, president, Multiple Myeloma Research Foundation JOE DEPINTO Head, cell, gene and advanced therapies, McKesson ANDREW OTOO President, global vaccines, Merck & Co. DANIEL PEREZ Director, health equity strategy, Worldwide Clinical Trials KIM RIBEIRO Former head, diversity and patient inclusion, AbbVie JADE SHIELDS Vice president, corporate affairs, Ferring Pharmaceuticals DR. JANE WILLIAMS Vice president, head of neuroscience, rare disease and pediatrics, Syneos Health CEM ZORLULAR CEO, Er-Kim Pharmaceuticals BIOTECH PATHFINDERS SHELLEY FORCE ALDRED CEO, co-founder, Rondo Therapeutics LYN BARANOWSKI CEO, Avalyn Pharma DAVID BEARSS CEO, president, co-founder, Halia Therapeutics HOWARD BERMAN CEO, founder, Coya Therapeutics SARAH BOYCE CEO, president, Avidity Biosciences DR. MICHAEL EHLERS CEO, founder, president, Ascidian Therapeutics; chief scientific officer, general partner, Apple Tree Partners JULIE GILMORE Vice president, global head, Lilly Gateway Labs JENNIFER GOOD CEO, co-founder, president, Trevi Therapeutics AVAK KAHVEJIAN General partner, Flagship Pioneering DR. ANDREW SCHARENBERG CEO, co-founder, Umoja Biopharma MARI ANNE SNOW CEO, co-founder, Eascra Biotech RYAN SPENCER CEO, Dynavax Technologies BRIAN TAYLOR CEO, SmartLabs CANCER CARE VISIONARIES DR. HESHAM ABDULLAH Senior vice president, global head, oncology R&D, GSK JASON BOCK CEO, co-founder, CTMC ARNON CHAIT CEO, president, Cleveland Diagnostics RAFFAELE COLOMBO Associate director, medicinal chemistry, Zymeworks DR. YUSRI ELSAYED Senior vice president, global oncology therapeutic area head, Johnson & Johnson MARK ERLANDER CEO, Cardiff Oncology DR. MARJORIE GREEN Senior vice president, head, oncology clinical development, Merck & Co. RAQUEL IZUMI Chief operations officer, president, founder, Vincerx Pharma DR. BILJANA NAUMOVIC President, U.S. oncology, solid tumors, Johnson & Johnson DR. AMITA PATNAIK Co-founder, co-director of clinical research, The START Center for Cancer Research DR. MARY PINDER-SCHENCK Former vice president, head, global oncology medical affairs, Daiichi Sankyo AMOOLYA SINGH Chief scientific officer, senior vice president of research, Grail AMIRALI TALASAZ Co-CEO, co-founder, director, Guardant Health CARDIOMETABOLIC ALL-STARS ROBERT BLUM CEO, president, Cytokinetics KRISTEN FORTNEY CEO, co-founder, BioAge Labs VIPIN GARG CEO, president, Altimmune NEGELLE MORRIS Senior vice president, head, U.S. cardiometabolic sales, Novo Nordisk ROHAN PALEKAR CEO, 89bio DR. REBECCA TAUB Chief medical officer, founder, director, president of R&D, Madrigal Pharmaceuticals CELL AND GENE THERAPY PIONEERS DR. ERIC ADLER Chief medical officer, head, research, Lexeo Therapeutics DR. ARIS BARAS Senior vice president, Regeneron Genetics Center, Regeneron Pharmaceuticals BRUCE LAHN Chief scientist, founder, VectorBuilder BENJAMIN OAKES CEO, co-founder, Scribe Therapeutics NIA TATSIS Chief regulatory and quality officer, executive vice president, Vertex Pharmaceuticals JOE TRUITT CEO, iEcure KRISTIN YAREMA CEO, president, Poseida Therapeutics HEIDI ZHANG Executive vice president, head, technical operations, Tune Therapeutics RARE DISEASE WARRIORS DR. SORAYA BEKKALI Senior vice president, head, Europe, Canada and international business, Alexion DR. HEATHER LAU Executive director, global clinical development, Ultragenyx Pharmaceutical CARLOS MARTIN Chief commercial operations and revenue officer, Rocket Pharmaceuticals WILLIAM ROTE Senior vice president, R&D, Travere Therapeutics CHERYL SCHWARTZ Senior vice president, U.S. rare disease business unit lead, U.S. commercial operations lead, Takeda TECH AND AI WIZARDS ARUNA ADHIKARI Global head, product, clinical technologies, IQVIA ARDY ARIANPOUR CEO, co-founder, Seqster CHRIS BOUTON Senior vice president, head, artificial intelligence, Certara DAVID BENSHOOF KLEIN CEO, founder, Click Therapeutics NIKOLAUS KRALL Executive vice president, precision medicine, Exscientia NIVEN NARAIN CEO, president, chairman, BPGbio VENKAT SETHURAMAN Senior vice president, global biometrics and data sciences, Bristol Myers Squibb DR. ERIC WALK Chief medical officer, PathAI Filed Under: PharmaVoice 100 * * * * * * purchase licensing rights EDITORS’ PICK * Douglas Cliff via Getty Images FDA’S GLP-1 DECISION KICKS OFF ‘UNPRECEDENTED’ TUSSLE OVER SHORTAGE After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders. By Amy Baxter • Oct. 21, 2024 PHARMAVOICE STORIES AND INSIGHTS DELIVERED TO YOUR INBOX Get the free daily newsletter read by industry leaders Email: * Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Sign up A valid email address is required. Please select at least one newsletter. COMPANY ANNOUNCEMENTS View all | Post a press release Science-led selling strategies to supercharge your growth in 2025 From Decision Design October 20, 2024 Laxxon Medical to Present Innovative Oral GLP-1 Agonist including Multi-Compartment Micro-Tabl… From Laxxon Medical October 18, 2024 Want to share a company announcement with your peers? Get started ➔ Read next * Douglas Cliff via Getty Images FDA’S GLP-1 DECISION KICKS OFF ‘UNPRECEDENTED’ TUSSLE OVER SHORTAGE After initially declaring the shortage of Eli Lilly’s diabetes and weight loss drugs over, the FDA changed its mind and re-opened the door for GLP-1 compounders. By Amy Baxter • Oct. 21, 2024 Latest in PharmaVoice 100 * 2024 PharmaVoice 100s: Patient Champions By Meagan Parrish * 2024 PharmaVoice 100s: Cardiometabolic All-Stars By Amy Baxter * 2024 PharmaVoice 100s: Trailblazers By Meagan Parrish -------------------------------------------------------------------------------- * * * * EXPLORE * About * Editorial Team * Contact Us * Newsletter * Purchase Licensing Rights * Press Releases REACH OUR AUDIENCE * Advertising * Post a press release * Promote an event -------------------------------------------------------------------------------- image/svg+xml Industry Dive is an Informa business © 2024 Industry Dive. All rights reserved. | View our other publications | Privacy policy | Terms of use | Take down policy. Cookie Preferences / Do Not Sell Search * Home * Voices * Q&A * Profiles * Biotech Spotlight * First 90 Days * Opinions * Topics * Biotech * Commercialization * Leadership * Manufacturing * Patient * Pharma * Policy & Regulation * Research & Development * Library * Events * Press Releases * PharmaVoice 100 * Nominate * 2024 PV100 * 2023 PV100 GET PHARMAVOICE IN YOUR INBOX The free newsletter covering the top industry headlines Email: * Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Sign up A valid email address is required. Please select at least one newsletter.